Skip to main content
. 2022 Jan 29;50(3):699–707. doi: 10.1007/s15010-021-01743-1

Table 2.

Clinical outcomes of patients with AECOPD with and without confirmed influenza diagnosis

Variable AECOPD with influenza AECOPD without influenza OR/MD p
Cases, n 1004 67,688
Age distribution n (%) n (%) 0.859
 40–44 years 6 (0.6) 408 (0.6)
 45–49 years 20 (2.0) 1120 (1.7)
 50–54 years 38 (3.8) 2328 (3.4)
 55–59 years 61 (6.1) 4415 (6.5)
 60–64 years 97 (9.7) 6703 (9.9)
 65–69 years 145 (14.4) 9723 (14.4)
 70–74 years 197 (19.6) 11,954 (17.7)
 75–79 years 171 (17.0) 11,809 (17.4)
 80–84 years 159 (15.8) 10,613 (15.7)
 85–89 years 81 (8.1) 6297 (9.3)
 90–94 years 26 (2.6) 2028 (3.0)
 95 + years 3 (0.3) 290 (0.4)
Female, % 46 45 OR: 1.05 0.443
(95% CI 0.93–1.19)
Outcomes
 Mean LOS, days 10.9 11.5 Adj. MD: − 0.61 0.083
(95% CI − 1.29 to 0.08)
 In-hospital mortality, % 3.3 5.5 Adj. OR: 0.59 0.01
(95% CI 0.42–0.84)
 Risk of re-hospitalization, % 29 37 Adj. OR: 0.71  < 0.001
(95% CI 0.62–0.89)
 Aspergillosis, % 0.2 0.2 Adj. OR: 1.13 0.998
(95% CI 0.28–4.58)

OR odds ratio; MD mean difference; p p value; CI confidence interval